GE HealthCare Technologies (GEHC) Total Liabilities (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Total Liabilities came in at $26.0 billion in Q2 2026, up 1.87% YoY from $25.5 billion in Q2 2025, and down 0.76% on a QoQ basis from $26.2 billion in Q1 2026.
GE HealthCare Technologies (GEHC) Total Liabilities (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Total Liabilities data on file, last reported at $26.0 billion in Q2 2026.
- Quarterly Total Liabilities rose 1.87% year-over-year to $26.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $26.0 billion (up 1.87% YoY) and the FY2025 annual result came in at $26.3 billion, up 7.65% from the prior year.
- Total Liabilities declined to $26.0 billion in Q2 2026, from $26.2 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $26.3 billion in Q4 2025 to a low of $17.9 billion in Q4 2022.
- A 5-year average of $24.8 billion and a median of $25.1 billion in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities jumped 40.1% — and 2024, when it slipped 4.52%.
- Tracing GEHC's Total Liabilities over 5 years: stood at $17.9 billion in 2022, then jumped by 40.1% to $25.1 billion in 2023, then decreased by 2.81% to $24.4 billion in 2024, then rose by 7.65% to $26.3 billion in 2025, then slipped by 1.06% to $26.0 billion in 2026.
- The last three Total Liabilities figures came in at $26.0 billion (Q2 2026), $26.2 billion (Q1 2026), and $26.3 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 10.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.03 Bn |
| Mar 31, 2026 | 26.23 Bn |
| Dec 31, 2025 | 26.31 Bn |
| Sep 30, 2025 | 25.91 Bn |
| Jun 30, 2025 | 25.55 Bn |
| Mar 31, 2025 | 24.17 Bn |
| Dec 31, 2024 | 24.44 Bn |
| Sep 30, 2024 | 25.34 Bn |
| Jun 30, 2024 | 23.86 Bn |
| Mar 31, 2024 | 24.61 Bn |
| Dec 31, 2023 | 25.14 Bn |
| Sep 30, 2023 | 25.08 Bn |
| Jun 30, 2023 | 24.99 Bn |
| Mar 31, 2023 | 25.74 Bn |
| Dec 31, 2022 | 17.95 Bn |